Principal Financial Group Inc Novavax Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

A detailed history of Principal Financial Group Inc transactions in Novavax Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 12,419 shares of NVAX stock, worth $113,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,419

Previous 23,597 47.37%

Holding current value

$113,261

Previous $298,000 47.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$10.71 - $17.11 $119,716 - $191,255	-11,178 Reduced 47.37%	12,419 $156,000
Q2 2024 Jul 29, 2024	SELL	$3.89 - $20.97 $12,020 - $64,797	-3,090 Reduced 11.58%	23,597 $298,000
Q1 2024 Apr 29, 2024	BUY	$3.76 - $6.02 $7,392 - $11,835	1,966 Added 7.95%	26,687 $127,000
Q4 2023 Feb 07, 2024	BUY	$4.8 - $7.67 $5,851 - $9,349	1,219 Added 5.19%	24,721 $118,000
Q3 2023 Nov 02, 2023	BUY	$6.81 - $9.74 $483 - $691	71 Added 0.3%	23,502 $170,000
Q2 2023 Aug 07, 2023	BUY	$6.67 - $9.52 $22,824 - $32,577	3,422 Added 17.1%	23,431 $174,000
Q1 2023 May 09, 2023	SELL	$5.76 - $12.48 $10,690 - $23,162	-1,856 Reduced 8.49%	20,009 $138,000
Q4 2022 Feb 09, 2023	BUY	$8.86 - $25.04 $34,926 - $98,707	3,942 Added 21.99%	21,865 $224,000
Q3 2022 Nov 09, 2022	SELL	$18.2 - $76.12 $25,407 - $106,263	-1,396 Reduced 7.23%	17,923 $326,000
Q2 2022 Aug 10, 2022	BUY	$36.28 - $75.29 $55,508 - $115,193	1,530 Added 8.6%	19,319 $994,000
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $72,867 - $149,330	-1,045 Reduced 5.55%	17,789 $1.31 Million
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $3.74 Million - $6.06 Million	-27,815 Reduced 59.63%	18,834 $2.69 Million
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $3.92 Million - $5.96 Million	22,033 Added 89.51%	46,649 $9.67 Million
Q2 2021 Aug 10, 2021	BUY	$121.0 - $257.67 $332,145 - $707,304	2,745 Added 12.55%	24,616 $5.23 Million
Q1 2021 May 10, 2021	BUY	$112.98 - $319.93 $242,681 - $687,209	2,148 Added 10.89%	21,871 $3.97 Million
Q4 2020 Feb 08, 2021	BUY	$78.74 - $139.5 $356,455 - $631,516	4,527 Added 29.79%	19,723 $2.2 Million
Q3 2020 Nov 06, 2020	SELL	$79.44 - $178.51 $145,534 - $327,030	-1,832 Reduced 10.76%	15,196 $1.65 Million
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $236,008 - $1.42 Million	17,028 New	17,028 $1.42 Million

Others Institutions Holding NVAX

# of Institutions

286

Shares Held

84.8M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Novavax Inc Transaction History